Analyst Ratings for Astrana Health, Inc (ASTH)
ASTH Rating Summary
ASTH Price Target Summary
- Highest: $50.00 (Barclays)
- Lowest: $37.00 (Jefferies)
- Average: $44.17
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$44.17 (+15.1%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
Avg. $ Target:
$44.17 (+15.1%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/26/2026 | Barclays | Andrew Mok | Upgrade | Overweight (Equalweight) |
50.00 (37.00) |
37.85 (38.38) |
1.4% | Details |
| 12/12/2025 | Needham » Updated 5/8/2026 |
Matthew Shea | New Coverage | Buy (N/A) |
41.00 (30.00) |
22.46 (38.38) |
70.88% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
